[1]林 燕,史瑶平,汤晓寅,等.超声引导射频消融在较大乳腺纤维腺瘤治疗中的应用[J].介入放射学杂志,2023,32(06):560-564.
　LIN Yan,SHI Yaoping,TANG Xiaoyin,et al.The application of ultrasound-guided radiofrequency ablation in the treatment of large breast fibroadenoma[J].journal interventional radiology,2023,32(06):560-564.

点击复制

超声引导射频消融在较大乳腺纤维腺瘤治疗中的应用()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］ Ackerman LV，Mucciardi AN，Gose EE，et al. Classification of benign and malignant breast tumors on the basis of 36 radiographic properties［J］. Cancer， 1973， 31： 342-352.
［2］ Carty NJ，Carter C，Rubin C，et al. Management of fibroadenoma of the breast［J］. Ann R Coll Surg Engl， 1995， 77： 127- 130.
［3］ Yelland A，Gazet JC，Coombes RC. Conservative management of fibroadenoma of the breast［J］. Br J Surg， 1996， 83： 1653.
［4］ Jang JY，Kim SM，Kim JH，et al. Clinical significance of interval changes in breast lesions initially categorized as probably benign on breast ultrasound［J］. Medicine（Baltimore）， 2017， 96： e6415.
［5］ Dyrstad SW，Yan Y，Fowler AM，et al. Breast cancer risk associated with benign breast disease： systematic review and meta- analysis［J］. Breast Cancer Res Treat， 2015， 149： 569- 575.
［6］ Meloni GB，Dessole S，Becchere MP，et al. Ultrasound- guided mammotome vacuum biopsy for the diagnosis of impalpable breast lesions［J］. Ultrasound Obstet Gynecol， 2001， 18： 520- 524.
［7］ Jiang Y，Lan H， Ye Q， et al. Mammotome ?誖 biopsy system for the resection of breast lesions： clinical experience in two high- volume teaching hospitals［J］. Exp Ther Med， 2013， 6： 759- 764.
［8］ Pan S，Liu W，Jin K，et al. Ultrasound- guided vacuum- assisted breast biopsy using mammotome biopsy system for detection of breast cancer： results from two high volume hospitals［J］. Int J Clin Exp Med， 2014， 7： 239- 246.
［9］ Luo HJ，Chen X，Tu G，et al. Therapeutic application of ultrasound- guided 8- gauge mammotome system in presumed benign breast lesions［J］. Breast J， 2011， 17： 490- 497.
［10］ Tavares ECA，Freitas S，Portilha A，et al. Efficacy and safety of percutaneous radiofrequency thermal ablation in the treatment of lung cancer lesions［J］. Acta Med Port， 2015， 28： 63- 69.
［11］ Kitchin D，Lubner M， Ziemlewicz T，et al. Microwave ablation of malignant hepatic tumours： intraperitoneal fluid instillation prevents collateral damage and allows more aggressive case selection［J］. Int J Hyperthermia， 2014， 30： 299- 305.
［12］ Meyer J，Toomay S.Update on treatment of liver metastases： focus on ablation therapies［J］. Curr Oncol Rep， 2015， 17： 420.
［13］ 程 芳，王立平，徐 栋． 超声引导下热消融治疗甲状腺良性大结节的临床应用价值［J］． 介入放射学杂志， 2021， 30：364- 367．
［14］ Cui R，Wu H，Xu J，et al. Volume reduction for≥2 cm benign breast lesions after ultrasound- guided microwave ablation with a minimum 12- month follow- up［J］. Int J Hyperthermia， 2021， 38： 341- 348.
［15］ Li P，Tang XY T，Cui D，et al. Evaluation of the safety and efficacy of percutaneous radiofrequency ablation for treating multiple breast fibroadenoma［J］. J Cancer Res Ther， 2016， 12： C138- C142.
［16］ 周 南． 乳腺良性病变微波消融治疗的现状与进展［J］． 中国微创外科杂志， 2020， 20：369- 372．
［17］ 于 杰，梁 萍． 微波与射频消融的技术现状和肝癌临床治疗对比［J］． 医学研究杂志， 2008， 37：21- 24．
［18］ Cao J，Fan P，Wang F，et al. Application of contrast- enhanced ultrasound in minimally invasive ablation of benign thyroid nodules［J］. J Interv Med， 2022， 5： 32- 36.
［19］ Zhang W，Li JM，He W，et al. Ultrasound- guided percutaneous microwave ablation for benign breast lesions： evaluated by contrast- enhanced ultrasound combined with magnetic resonance imaging［J］. J Thorac Dis， 2017， 9： 4767- 4773.